Logo image of SVRE

SAVERONE 2014 LTD -ADR (SVRE) Stock Fundamental Analysis

NASDAQ:SVRE - Nasdaq - US80516T1051 - ADR - Currency: USD

2.17  -0.17 (-7.26%)

After market: 2.33 +0.16 (+7.37%)

Fundamental Rating

2

Taking everything into account, SVRE scores 2 out of 10 in our fundamental rating. SVRE was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. SVRE has a bad profitability rating. Also its financial health evaluation is rather negative. SVRE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SVRE has reported negative net income.
In the past year SVRE has reported a negative cash flow from operations.
SVRE had negative earnings in each of the past 5 years.
SVRE had a negative operating cash flow in each of the past 5 years.
SVRE Yearly Net Income VS EBIT VS OCF VS FCFSVRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

SVRE has a worse Return On Assets (-146.69%) than 95.20% of its industry peers.
The Return On Equity of SVRE (-328.67%) is worse than 96.80% of its industry peers.
Industry RankSector Rank
ROA -146.69%
ROE -328.67%
ROIC N/A
ROA(3y)-114.85%
ROA(5y)-103.98%
ROE(3y)-247.57%
ROE(5y)-200.21%
ROIC(3y)N/A
ROIC(5y)N/A
SVRE Yearly ROA, ROE, ROICSVRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

SVRE has a Gross Margin of 36.48%. This is in the better half of the industry: SVRE outperforms 62.40% of its industry peers.
SVRE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SVRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y8.11%
SVRE Yearly Profit, Operating, Gross MarginsSVRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

2

2. Health

2.1 Basic Checks

SVRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SVRE has been increased compared to 1 year ago.
SVRE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SVRE has been reduced compared to a year ago.
SVRE Yearly Shares OutstandingSVRE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SVRE Yearly Total Debt VS Total AssetsSVRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SVRE has an Altman-Z score of -13.20. This is a bad value and indicates that SVRE is not financially healthy and even has some risk of bankruptcy.
SVRE has a Altman-Z score of -13.20. This is amonst the worse of the industry: SVRE underperforms 96.80% of its industry peers.
SVRE has a Debt/Equity ratio of 0.65. This is a neutral value indicating SVRE is somewhat dependend on debt financing.
SVRE has a worse Debt to Equity ratio (0.65) than 82.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z -13.2
ROIC/WACCN/A
WACC5.69%
SVRE Yearly LT Debt VS Equity VS FCFSVRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.82 indicates that SVRE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.82, SVRE is doing worse than 67.20% of the companies in the same industry.
SVRE has a Quick Ratio of 1.40. This is a normal value and indicates that SVRE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SVRE (1.40) is worse than 62.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.4
SVRE Yearly Current Assets VS Current LiabilitesSVRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

SVRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.07%, which is quite impressive.
The Revenue for SVRE has decreased by -38.13% in the past year. This is quite bad
Measured over the past years, SVRE shows a very strong growth in Revenue. The Revenue has been growing by 81.69% on average per year.
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.46%
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y55.22%
Revenue growth 5Y81.69%
Sales Q2Q%-3.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 194.03% on average over the next years. This is a very strong growth
EPS Next Y-10273.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year318.51%
Revenue Next 2Y194.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SVRE Yearly Revenue VS EstimatesSVRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
SVRE Yearly EPS VS EstimatesSVRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -2K -4K -6K -8K -10K

0

4. Valuation

4.1 Price/Earnings Ratio

SVRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SVRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SVRE Price Earnings VS Forward Price EarningsSVRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SVRE Per share dataSVRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SVRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SAVERONE 2014 LTD -ADR

NASDAQ:SVRE (6/20/2025, 8:00:00 PM)

After market: 2.33 +0.16 (+7.37%)

2.17

-0.17 (-7.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-20 2022-09-20/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-86.53%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap1.34M
Analysts82.86
Price Target15.51 (614.75%)
Short Float %N/A
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.39%
PT rev (3m)669.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-65869.4%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-19.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.77
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-28.55
EYN/A
EPS(NY)-3005.64
Fwd EYN/A
FCF(TTM)-16.06
FCFYN/A
OCF(TTM)-16.03
OCFYN/A
SpS0.78
BVpS4.95
TBVpS4.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.69%
ROE -328.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.48%
FCFM N/A
ROA(3y)-114.85%
ROA(5y)-103.98%
ROE(3y)-247.57%
ROE(5y)-200.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y8.11%
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.9%
Cap/Sales 4.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.4
Altman-Z -13.2
F-Score4
WACC5.69%
ROIC/WACCN/A
Cap/Depr(3y)18.53%
Cap/Depr(5y)29.32%
Cap/Sales(3y)4.87%
Cap/Sales(5y)16.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.46%
EPS Next Y-10273.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y55.22%
Revenue growth 5Y81.69%
Sales Q2Q%-3.61%
Revenue Next Year318.51%
Revenue Next 2Y194.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.75%
OCF growth 3YN/A
OCF growth 5YN/A